The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which also identified differences based on sex, age, and timing of onset. Medscape Medical News
Author: Medscape
AAN 2025: The Impact of Updated Diagnostic Criteria in RRMS
Dr Pavan Bhargava comments on the practical implications of the revised diagnostic criteria, which allow for earlier diagnosis. Medscape
EMA Recommends Tepezza for Severe Thyroid Eye Disease
Teprotumumab is a fully human IgG1 monoclonal antibody that inhibits tissue inflammation and remodeling. Medscape Medical News
FDA Okays Upadacitinib for Giant Cell Arteritis
This is the first and only oral JAK inhibitor indicated for giant cell arteritis, according to the manufacturer AbbVie. Medscape Medical News
Red-Light Therapy May Reduce Cone Density in Myopic Children
Medscape Medical News
Are You Prescribing Acne Antibiotics Right? Key Tips
Optimize your acne treatment approach with these key tips on using antibiotics properly, combining therapies, and ensuring the best patient outcomes. Medscape Medical News
Young Women Binge Drinking at Higher Rates Than Men
Young women are binge drinking more than young men. Medscape Medical News
Stop Smoking Now to Protect Your Vision, Experts Warn
A “meta–meta-analysis” highlights the negative effects of smoking on ocular health, particularly concerning age-related macular degeneration, cataracts, and primary open-angle glaucoma. Medscape Medical News
UK Consultants Restore Sight for 24 Injured Protesters
Two consultants from London’s Moorfields Eye Hospital restored vision for 24 young men in Bangladesh, following severe eye trauma sustained during pro-democracy protests. Medscape News UK
Slow Adalimumab Tapering May Cut Risk for Uveitis Relapse
A retrospective cohort analysis shows that pediatric patients with noninfectious uveitis face lower recurrence rates when adalimumab is tapered slowly after remission. Medscape Medical News
JAK Inhibitors Offer Some Improvement for Pediatric Uveitis
Only half of patients showed clinical improvement attributed to the medication, but only one new complication occurred. Medscape Medical News
Probiotic Formula May Protect Infants With Milk Allergy
Children with cow’s milk protein allergy may have a lower incidence of allergic manifestations when their diet includes a probiotic-enhanced formula, new research shows. Medscape Medical News
Social Media Aids Post-Op Care in Ectopia Lentis
Using a smartphone application for health education and reminders enhances parental understanding and boosts follow-up visits in children undergoing surgery for CEL. Medscape Medical News
Modest Effects of Valacyclovir in Herpes Zoster Eye Disease
Administration of low-dose valacyclovir over a year does not significantly reduce the occurrence of herpes zoster ophthalmicus but shows potential benefits over time. Medscape Medical News
Updated Rosacea Treatment Algorithms Available
Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach wherein signs and symptoms guide diagnosis and treatment choices. Medscape Medical News
FDA Approves First and Only Therapy for IgG4-RD
The CD19+ B-Cell targeted therapy reduced flare risk by 87% in a phase 3 clinical trial. Medscape Medical News
Seven Years, a Hidden Metal Body, and Restored Eyesight
A metallic fragment, missed after a workplace injury, is removed 7 years later, fully restoring a 59-year-old man’s vision. Medscape UK
How Office Props Improve Patient Outcomes
Showing patients props and other visual aids improves recall of information, motivates patients, said doctors who have expanded their ‘black bags.’ Medscape Medical News
Early-Onset Atopic Dermatitis Raises Uveitis Risk in Kids
A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis, highlighting a need for ophthalmologic monitoring in youth. Medscape Medical News
US FDA Declines to Approve Aldeyra’s Eye Disease Drug
The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics treatment for dry eye disease, the company said on Thursday, sending its shares… Reuters Health Information